Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 9570171, 7 pages
http://dx.doi.org/10.1155/2016/9570171
Clinical Study

Therapeutic Outcome of Second Primary Malignancies in Patients with Well-Differentiated Thyroid Cancer

1Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, No. 5, Fu-Shin Street, Guishan District, Taoyuan 333, Taiwan
2Department of Radiation Oncology, Chang Gung Memorial Hospital, Chang Gung University, No. 5, Fu-Shin Street, Guishan District, Taoyuan 333, Taiwan
3Department of Pathology, Chang Gung Memorial Hospital, Chang Gung University, No. 5, Fu-Shin Street, Guishan District, Taoyuan 333, Taiwan
4Department of General Surgery, Chang Gung Memorial Hospital, Chang Gung University, No. 5, Fu-Shin Street, Guishan District, Taoyuan 333, Taiwan

Received 9 November 2015; Revised 22 February 2016; Accepted 16 March 2016

Academic Editor: Thomas J. Fahey

Copyright © 2016 Miaw-Jene Liou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Supplemental table A illustrated clinical features of 200 secondary primary malignancy (SPM) patients in anachronous with synchronous and metachronous two groups. Supplemental table B showed the difference between no SPM or anachronous with synchronous patients and metachronous SPM patients. Supplemental figure showed age distribution and case number of top three metachronous SPM.

  1. Supplementary Material